SHERWIN STEPHEN A
Director · 4 filings · Latest: Jun 9, 2026
BIOGEN INC.
NEUROCRINE BIOSCIENCES INC
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
NBIX | SHERWIN STEPHEN A | Director | Jun 5, 2026 | Sale | $165.32 | 25,000 | $4.1M | 15,860 | |
NBIX | SHERWIN STEPHEN A | Director | Jun 5, 2026 | Option Exercise | $64.10 | 25,000 | $1.6M | 40,860 | |
NBIX | STEPHEN SHERWIN | — | Jun 5, 2026 | Proposed Sale | $167.35 | 25,000 | $4.2M | — | |
NBIX | SHERWIN STEPHEN A | Director | May 21, 2026 | Option Exercise | $0.00 | 3,318 | — | 15,860 | |
BIIB | STEPHEN A SHERWIN | — | Mar 7, 2025 | Proposed Sale | $147.37 | 8,760 | $1.3M | — | |
NBIX | STEPHEN A SHERWIN | — | Feb 13, 2025 | Proposed Sale | $117.18 | 13,831 | $1.6M | — |